贝沙罗汀和布地奈德在小细胞肺癌基因工程小鼠模型中的预防作用。
Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer.
机构信息
Department of Surgery and The Alvin J. Siteman Cancer Center and Division of Comparative Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
出版信息
Cancer Prev Res (Phila). 2009 Dec;2(12):1059-64. doi: 10.1158/1940-6207.CAPR-09-0221. Epub 2009 Nov 24.
Abstract
In the present study, we examined the effect of bexarotene (Targretin) and budesonide in the chemoprevention of small cell lung carcinoma using a lung-specific knockout model of Rb1 and p53. Upon treatment with bexarotene, tumor incidence, number, and load were significantly reduced (P < 0.05). Budesonide treatment trended to inhibition, but the effect was not statistically significant (P > 0.05). Immunohistochemical staining indicated that bexarotene treatment decreased cell proliferation and increased apoptosis in tumors. The Rb1/p53 gene-targeted mouse seems to be a valuable model for chemopreventive studies on human small cell lung cancer. Our results indicate that the retinoid X receptor agonist bexarotene may be a potent chemopreventive agent in this cancer type.
摘要
在本研究中，我们使用 Rb1 和 p53 肺特异性敲除模型，研究了贝沙罗汀（Targretin）和布地奈德在小细胞肺癌化学预防中的作用。贝沙罗汀治疗可显著降低肿瘤发生率、数量和负荷（P<0.05）。布地奈德治疗呈抑制趋势，但无统计学意义（P>0.05）。免疫组化染色表明，贝沙罗汀治疗可减少肿瘤细胞增殖并增加细胞凋亡。Rb1/p53 基因靶向小鼠似乎是人类小细胞肺癌化学预防研究的有价值模型。我们的结果表明，视黄醇 X 受体激动剂贝沙罗汀可能是这种癌症类型的有效化学预防剂。
相似文献
1
Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer.贝沙罗汀和布地奈德在小细胞肺癌基因工程小鼠模型中的预防作用。
Cancer Prev Res (Phila). 2009 Dec;2(12):1059-64. doi: 10.1158/1940-6207.CAPR-09-0221. Epub 2009 Nov 24.
2
Aerosolized bexarotene inhibits lung tumorigenesis without increasing plasma triglyceride and cholesterol levels in mice.雾化贝沙罗汀可抑制小鼠肺部肿瘤的发生，而不增加血浆甘油三酯和胆固醇水平。
Cancer Prev Res (Phila). 2011 Feb;4(2):270-6. doi: 10.1158/1940-6207.CAPR-10-0246. Epub 2010 Dec 16.
3
Prevention of lung cancer progression by bexarotene in mouse models.贝沙罗汀在小鼠模型中对肺癌进展的预防作用
Oncogene. 2006 Mar 2;25(9):1320-9. doi: 10.1038/sj.onc.1209180.
4
Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.在p53基因缺失的小鼠乳腺肿瘤模型中，通过三类化学预防剂在肿瘤前阶段鉴定调控基因。
Cancer Prev Res (Phila). 2009 Feb;2(2):175-84. doi: 10.1158/1940-6207.CAPR-08-0104. Epub 2009 Jan 27.
5
Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.使用类视黄醇贝沙罗汀、酪氨酸激酶抑制剂吉非替尼和塞来昔布预防p53基因缺失的乳腺上皮细胞发生肿瘤。
Cancer Prev Res (Phila). 2009 Feb;2(2):168-74. doi: 10.1158/1940-6207.CAPR-08-0107. Epub 2009 Jan 27.
6
Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.视黄酸类化合物在非小细胞肺癌中的新作用：聚焦于贝沙罗汀。
Oncologist. 2005 Jan;10(1):22-33. doi: 10.1634/theoncologist.10-1-22.
7
The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.维甲酸X受体激动剂贝沙罗汀（他扎罗汀）可协同增强细胞毒性药物对非小细胞肺癌细胞的生长抑制活性。
Lung Cancer. 2005 Oct;50(1):9-18. doi: 10.1016/j.lungcan.2005.05.008.
8
Prevention of mouse lung tumors by combinations of chemopreventive agents using concurrent and sequential administration.联合应用化学预防剂通过同时和序贯给药预防小鼠肺癌。
Anticancer Res. 2011 Oct;31(10):3279-84.
9
Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.RXR 选择性维甲酸倍他罗汀对 Apc(Min/+) 小鼠肠道肿瘤的化学预防作用。
Neoplasia. 2012 Feb;14(2):159-68. doi: 10.1593/neo.111440.
10
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.视黄酸类药物贝沙罗汀可预防MMTV-erbB2小鼠癌前病变的发生。
Br J Cancer. 2008 Apr 22;98(8):1380-8. doi: 10.1038/sj.bjc.6604320. Epub 2008 Mar 25.
引用本文的文献
1
Inhaled Medicines for Targeting Non-Small Cell Lung Cancer.用于靶向非小细胞肺癌的吸入药物。
Pharmaceutics. 2023 Dec 14;15(12):2777. doi: 10.3390/pharmaceutics15122777.
2
Mechanism of lnRNA-ICL involved in lung cancer development in COPD patients through modulating microRNA-19-3p/NKRF/NF-κB axis.长链非编码RNA-ICL通过调控微小RNA-19-3p/NKRF/核因子κB轴参与慢性阻塞性肺疾病患者肺癌发生发展的机制
Cancer Cell Int. 2023 Apr 3;23(1):58. doi: 10.1186/s12935-023-02900-2.
3
Consequences of Vitamin A Deficiency: Immunoglobulin Dysregulation, Squamous Cell Metaplasia, Infectious Disease, and Death.维生素 A 缺乏的后果：免疫球蛋白失调、鳞状细胞化生、传染病和死亡。
Int J Mol Sci. 2020 Aug 4;21(15):5570. doi: 10.3390/ijms21155570.
4
The potential of retinoids for combination therapy of lung cancer: Updates and future directions.维 A 酸类药物治疗肺癌的联合疗法潜力：最新进展及未来方向
Pharmacol Res. 2019 Sep;147:104331. doi: 10.1016/j.phrs.2019.104331. Epub 2019 Jun 26.
5
Retinoids and rexinoids in cancer prevention: from laboratory to clinic.类视黄醇与类视黄酸X受体激动剂在癌症预防中的应用：从实验室到临床
Semin Oncol. 2016 Feb;43(1):49-64. doi: 10.1053/j.seminoncol.2015.09.002. Epub 2015 Sep 25.
6
Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.吸烟者肺癌发生的药理学调控：临床前和临床证据
Trends Pharmacol Sci. 2016 Feb;37(2):120-142. doi: 10.1016/j.tips.2015.11.003. Epub 2015 Dec 23.
7
ccmGDB: a database for cancer cell metabolism genes.ccmGDB：一个癌细胞代谢基因数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D959-68. doi: 10.1093/nar/gkv1128. Epub 2015 Oct 30.
8
Relationships between pulmonary micro-RNA and proteome profiles, systemic cytogenetic damage and lung tumors in cigarette smoke-exposed mice treated with chemopreventive agents.香烟烟雾暴露小鼠经化学预防剂处理后肺内 microRNA 与蛋白质组谱、全身细胞遗传学损伤与肺肿瘤的关系。
Carcinogenesis. 2013 Oct;34(10):2322-9. doi: 10.1093/carcin/bgt178. Epub 2013 May 24.
9
Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).给予 RXR 激动剂：UAB30、4-甲基-UAB30 和 Targretin（贝沙罗汀）后大鼠肝脏基因表达的影响。
Mol Pharmacol. 2013 Mar;83(3):698-708. doi: 10.1124/mol.112.082404. Epub 2013 Jan 4.
10
Retinoid pathway and cancer therapeutics.视黄醇途径与癌症治疗学。
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1285-98. doi: 10.1016/j.addr.2010.07.003. Epub 2010 Aug 3.
本文引用的文献
1
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.合成三萜类化合物CDDO-甲酯和视黄酸类化合物LG100268对实验性雌激素受体阴性乳腺癌发生的预防和治疗作用
Clin Cancer Res. 2008 Jul 15;14(14):4556-63. doi: 10.1158/1078-0432.CCR-08-0040.
2
Glucocorticoid receptor overexpression exerts an antisurvival effect on human small cell lung cancer cells.糖皮质激素受体过表达对人小细胞肺癌细胞产生抗生存效应。
Oncogene. 2007 Nov 1;26(50):7111-21. doi: 10.1038/sj.onc.1210524. Epub 2007 May 14.
3
Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.肝X受体和视黄酸X受体激动剂可抑制小胶质细胞和星形胶质细胞的炎症反应。
J Neuroimmunol. 2007 Feb;183(1-2):50-9. doi: 10.1016/j.jneuroim.2006.11.007. Epub 2006 Dec 18.
4
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.糖皮质激素对癌细胞生长和化学敏感性的影响具有异质性，且需要高浓度的功能性糖皮质激素受体。
World J Gastroenterol. 2005 Oct 28;11(40):6373-80. doi: 10.3748/wjg.v11.i40.6373.
5
Prevention of mouse lung tumors by targretin.他扎罗汀预防小鼠肺部肿瘤
Int J Cancer. 2006 May 1;118(9):2359-62. doi: 10.1002/ijc.21618.
6
Prevention of lung cancer progression by bexarotene in mouse models.贝沙罗汀在小鼠模型中对肺癌进展的预防作用
Oncogene. 2006 Mar 2;25(9):1320-9. doi: 10.1038/sj.onc.1209180.
7
Mouse models for human lung cancer.人类肺癌的小鼠模型
Genes Dev. 2005 Mar 15;19(6):643-64. doi: 10.1101/gad.1284505.
8
Nonclassical retinoids and lung carcinogenesis.非经典类视黄醇与肺癌发生
Clin Lung Cancer. 2005 Jan;6(4):237-44. doi: 10.3816/CLC.2005.n.003.
9
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.在条件性小鼠模型中，通过Trp53和Rb1的体细胞失活诱导小细胞肺癌。
Cancer Cell. 2003 Sep;4(3):181-9. doi: 10.1016/s1535-6108(03)00220-4.
10
Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.p53和Ink4a/Arf均发生改变的小鼠肺部肿瘤的多样性和进展显著增加：布地奈德对野生型和突变型A/J小鼠的化学预防作用差异
Cancer Res. 2003 Aug 1;63(15):4389-95.
Zotero 插件